Dihydrochelerythrine Induced Ferroptosis via Glutathione Peroxidase 4 Downregulation in Prostate Cancer Cells
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202500968 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Aihua Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Xinxiang Central Hospital, Xinxiang, P. R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Benzophenanthridines, Down-Regulation, Ferroptosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hunan Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
The purpose of this study was to elucidate the role of dihydrochelerythrine (DHC) in prostate cancer and to explore its targets in DU145 and PC3 cells. DHC significantly inhibited the growth of both cell lines. RNA‐sequencing analysis revealed that ferroptosis‐related genes, including glutathione peroxidase 4 (GPX4) and light chain 3, were significantly downregulated in DHC‐treated DU145 cells. Molecular docking studies demonstrated significant interactions between DHC and the GPX4 protein, with a binding energy of ‐9.01 kcal/mol. Furthermore, GPX4 mRNA expression was significantly upregulated in 497 prostate tumor samples compared to normal tissue in the Cancer Genome Atlas prostate adenocarcinoma dataset. DHC markedly induced ferroptosis in DU145 and PC3 cells by suppressing GPX4 expression, increasing mitochondrial membrane density, and reducing/vanishing mitochondrial cristae, leading to lipid reactive oxygen species production. Treatment with Ferrostatin‐1 partially rescued the cell viability reduced by DHC. Collectively, these findings suggest that DHC may be a potential agent for inducing ferroptosis in prostate cancer cells by decreasing GPX4 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Xinxiang Central Hospital, Xinxiang, P. R. China.
- Hunan Provincial Key Laboratory for Synthetic Biology of Traditional Chinese Medicine, School of Pharmaceutical Sciences, Hunan University of Medicine, Huaihua, P. R. China.
- Xiangya Hospital, Central South University, Changsha, P. R. China.
- The Fourth Clinical College of Xinxiang Medical University, Xinxiang, P. R. China.
- Central Laboratory, Xinxiang Central Hospital, Xinxiang, P. R. China.
- Department of Gynecology Oncology, Xinxiang Central Hospital, Xinxiang, P. R. China.
ORCID-Profile: Yang Xie
Förderung
- National Natural Science Foundation of China
- Hunan Provincial Natural Science Foundation of China
Zitieren
APA
Xu, A., Xie, Y., Han, R., Zhong, J., Wang, Q., & Zhou, Q. (2025). Dihydrochelerythrine Induced Ferroptosis via Glutathione Peroxidase 4 Downregulation in Prostate Cancer Cells. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202500968
Vancouver
Xu A, Xie Y, Han R, Zhong J, Wang Q, Zhou Q. Dihydrochelerythrine Induced Ferroptosis via Glutathione Peroxidase 4 Downregulation in Prostate Cancer Cells. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202500968
BibTeX
@article{Xu2025,
author = {Xu, Aihua and Xie, Yang and Han, Ruobing and Zhong, Jiateng and Wang, Qianqing and Zhou, Qun},
title = {Dihydrochelerythrine Induced Ferroptosis via Glutathione Peroxidase 4 Downregulation in Prostate Cancer Cells},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202500968}
}
EUVIMED